Structure-Based Design for High-Hanging Vaccine Fruits

被引:6
作者
Back, Jaap W. [2 ]
Langedijk, Johannes P. M. [1 ]
机构
[1] Crucell Innovat & Discovery Lab, Leiden, Netherlands
[2] Pepscan Therapeut, Lelystad, Netherlands
来源
ADVANCES IN IMMUNOLOGY , VOL 114: SYNTHETIC VACCINES | 2012年 / 114卷
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; HIV-1; GP120; BROAD NEUTRALIZATION; CRYSTAL-STRUCTURES; MOUTH-DISEASE; BINDING MODE; GP41; EPITOPE;
D O I
10.1016/B978-0-12-396548-6.00002-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although vaccines have proven life saving against a myriad of infectious diseases, various pathogens have remained refractory to prophylaxis of their host by active immunization. New insights in the three dimensional (3D) structure, domain organization and dynamics of viral and bacterial surface proteins can guide the design of effective vaccines in several ways. In this review we highlight recent developments in structure-based vaccine design that are aimed at stabilization of native conformations and focusing immune response to conserved epitopes. Detailed 3D structures of pathogen surface proteins provide knowledge on how to minimize complex antigens or how to redesign the surface of an immunogen in order to induce only relevant neutralizing antibodies against a broad range of serotypes. Structure - based vaccines with reduced complexity and broad efficacy could greatly enhance the number of people that might benefit from the therapies that are developed.
引用
收藏
页码:33 / 50
页数:18
相关论文
共 82 条
[41]   Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus [J].
Langedijk, JPM ;
Schaaper, WMM ;
Meloen, RH ;
vanOirschot, JT .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :1249-1257
[42]   FIRST PEPTIDE VACCINE PROVIDING PROTECTION AGAINST VIRAL-INFECTION IN THE TARGET ANIMAL - STUDIES OF CANINE PARVOVIRUS IN DOGS [J].
LANGEVELD, JPM ;
CASAL, JI ;
OSTERHAUS, ADME ;
CORTES, E ;
DESWART, R ;
VELA, C ;
DALSGAARD, K ;
PUIJK, WC ;
SCHAAPER, WMM ;
MELOEN, RH .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4506-4513
[43]   Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy [J].
Law, Mansun ;
Cardoso, Rosa M. F. ;
Wilson, Ian A. ;
Burton, Dennis R. .
JOURNAL OF VIROLOGY, 2007, 81 (08) :4272-4285
[44]   Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses [J].
Li, Yun ;
Cleveland, Bradley ;
Klots, Igor ;
Travis, Bruce ;
Richardson, Barbra A. ;
Anderson, David ;
Montefiori, David ;
Polacino, Patricia ;
Hu, Shiu-Lok .
JOURNAL OF VIROLOGY, 2008, 82 (02) :638-651
[45]   Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein [J].
Liang, XP ;
Munshi, S ;
Shendure, J ;
Mark, G ;
Davies, ME ;
Freed, DC ;
Montefiori, DC ;
Shiver, JW .
VACCINE, 1999, 17 (22) :2862-2872
[46]   Molecular architecture of native HIV-1 gp120 trimers [J].
Liu, Jun ;
Bartesaghi, Alberto ;
Borgnia, Mario J. ;
Sapiro, Guillermo ;
Subramaniam, Sriram .
NATURE, 2008, 455 (7209) :109-U76
[47]   Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody [J].
Luftig, Micah A. ;
Mattu, Marco ;
Di Giovine, Paolo ;
Geleziunas, Romas ;
Hrin, Renee ;
Barbato, Gaetano ;
Bianchi, Elisabetta ;
Miller, Michael D. ;
Pessi, Antonello ;
Carfi, Andrea .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2006, 13 (08) :740-747
[48]   Engineering Novel Bioactive Mini-Proteins from Small Size Natural and De Novo Designed Scaffolds [J].
Martin, Loic ;
Vita, Claudio .
CURRENT PROTEIN & PEPTIDE SCIENCE, 2000, 1 (04) :403-430
[49]   Engineering Viable Foot-and-Mouth Disease Viruses with Increased Thermostability as a Step in the Development of Improved Vaccines [J].
Mateo, Roberto ;
Luna, Eva ;
Rincon, Veronica ;
Mateu, Mauricio G. .
JOURNAL OF VIROLOGY, 2008, 82 (24) :12232-12240
[50]   HIV-1 vaccine development: Constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb [J].
McGaughey, GB ;
Citron, M ;
Danzeisen, RC ;
Freidinger, RM ;
Garsky, VM ;
Hurni, WM ;
Joyce, JG ;
Liang, X ;
Miller, M ;
Shiver, J ;
Bogusky, MJ .
BIOCHEMISTRY, 2003, 42 (11) :3214-3223